COVID-19 Infection and Outcomes in Newborn Screening Cohorts of Sickle Cell Trait and Sickle Cell Disease in Michigan and Georgia
The sickle cell mutation increases morbidity in those with sickle cell disease (SCD) and potentially sickle cell trait, impacting pulmonary, coagulation, renal, and other systems that are implicated in COVID-19 severity. There are no population-based registries for hemoglobinopathies, and they are not tracked in COVID-19 testing.
Proposed citation: Paulukonis, S., Snyder, A., Smeltzer, M., Sutaria, A., Hurden, I., Latta, K., et al. (2023). COVID-19 infection and outcomes in newborn screening cohorts of sickle cell trait and sickle cell disease in Michigan and Georgia. Pediatric Hematology/Oncology, 45(4). 174-180. DOI: 10.1097/MPH.0000000000002671.
|COVID-19 Infection and Outcomes in Newborn Screening Cohorts of Sickle Cell Trait and Sickle Cell Disease in Michigan and Georgia||Download|
- 0.00 KB File Size
- April 24, 2023 Create Date
- June 14, 2023 Last Updated